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Abstract 
Infants with recurrent infection may be found to have hypogammaglobulinemia without impaired 
specific antibody responses.  Many of these infants will eventually be diagnosed with transient 
hypogammaglobulimenia of infancy after hypogammaglobulinemia has resolved.  This study used 
parametric survival analysis of 100 infants with hypogammaglobulinemia to evaluate parameters that 
predict time to normalization.  Aggregate initial immunoglobulin levels (IgG + IgA + IgM), viewed as a 
percentage of age-adjusted normal values, predicted time to resolution of hypogammaglobulinemia:  
the median time to resolution for the infants in the lowest quartile of aggregate immunoglobulin levels 
(≤81% of age-adjusted lower limits of normal) was greater than five years with 34% resolving in 3 years.  
For infants in the highest quartile (≥130% of age-adjusted lower limits of normal) the median time to 
resolution was 9.9 months with 77% resolving in 3 years (p = 0.008).  Initial IgG level, viewed as a 
percentage of age-adjusted normal values, also predicted time to resolution:    the median time to 
resolution in the lowest quartile (≤78% of age-adjusted lower limits of normal) was greater than 5 years 
with 36% resolving in 3 years.  For infants in the highest quartile (≥128%) the median time to resolution 
was 14.5 months with 70% resolving in 3 years (p = 0.010).  Male gender was also associated with more 
rapid resolution of hypogammaglobulinemia.  The median time to resolution in males was 13 months 
with 73% resolving in 3 years.  The median time to resolution in females was greater than 5 years, with 
32% resolving in 3 years.  These results suggest that if a term infant presents with 
hypogammaglobulinemia, protective specific antibody titers, and an absence of other known immune 
deficiency, initial immunoglobulin levels and gender may be used to predict time to normalization. 
Keywords  Hypogammaglobulinemia • immunoglobulins • immunity • infancy • primary 
immunodeficiency  
Introduction 
Infants with recurrent infection are often referred to allergists/immunologists because of 
concern about possible immune system dysfunction, and hypogammaglobulinemia, without impaired 
specific antibody responses, may be found.  Such infants are usually considered to have transient 
hypogammaglobulinemia of infancy (THI).  THI has been defined by the International Union of 
Immunological Societies (IUIS) as a transient delay reaching normal levels of IgG and IgA.[1]  However, it 
has recently been shown that infants with an isolated decrease in IgA are clinically similar to infants with 
decreased IgG and IgA.[2]  THI has been associated with increased production of TNF-alpha, TNF-beta 
and IL-10.[3]  A report in 1981 associated THI with numerical and functional deficiency of helper T-cells 
[4];   more recently, however, THI has been associated with a transient increase in numbers of 
regulatory T-cells.[5]   
Complicating the assessment and prognostication about infants with hypogammaglobulinemia is 
the reality that a diagnosis of THI can only be established in retrospect, after immunoglobulin levels 
have normalized.[6]  Without question, some Infants with hypogammaglobulinemia will not have 
resolution of their deficiency and those infants with persistent hypogammaglobulinemia may be at 
increased risk for recurrent infection and autoimmune disease.[7]   At the time of initial recognition of 
hypogammaglobulinemia in an infant, since this may be physiologic, immunologists are often finding 
with clinically relevant questions regarding the likely duration of hypogammaglobulinemia.  Previous 
studies have shown that males are more likely than females to have resolution of 
hypogammaglobulinemia during infancy,[8]  however, other than this observation, there has been little 
information that would allow an informed prediction about the probable time to resolution to 
hypogammaglobulinemia. The goal of this study was to define parameters, present at the time of 
diagnosis that might predict time to resolution of hypogammaglobulinemia. 
Methods 
Subjects  Between 1978-2011, 100 infants with hypogammaglobulinemia were identified during 
routine clinical evaluation in the Division of Allergy, Asthma and Clinical Immunology at A.I. duPont 
Hospital for Children (Wilmington, DE) and Thomas Jefferson University (Philadelphia, PA).  Infants were 
included in the study if they had an IgG and/or IgA level that was below the 5
th
 percentile of the age-
adjusted mean, were less than 24 months old at the time of diagnosis, were born at greater than 36 
weeks gestation, had evidence of protective diphtheria & tetanus titers following immunization, and had 
no other known primary immune deficiency.  Infants were excluded from the study if they were born 
prematurely (i.e. 37 weeks gestation), if diphtheria & tetanus antibody titers post immunization were 
not protective, or if there was another known primary immune deficiency.  The institutional IRB 
reviewed the protocol and waived the requirement for parental informed consent. 
Statistics  Infants were grouped into quartiles, on the basis of the sum of initial IgG + IgA + IgM, 
viewed as a percentage of the lower limit of age-appropriate normal values.  (See figure 1.)  In a 
separate analysis, infants were grouped into quartiles on the basis of the initial IgG, viewed as a 
percentage of the lower limit of age-appropriate normal values.  (See figure 2.)  And in a final analysis, 
infants were grouped using gender since earlier evaluations described gender difference.  Groups were 
compared with one another regarding time to resolution using interval censored data and parametric 
survival analysis (SAS version 9.1.3).  Interval censored data was used because an actual date of 
normalization is not known; only an interval during which a patient’s immunoglobulin levels normalized.  
Prior studies checked the reasonableness of this model by Kaplan-Meier curves, using interval midpoints 
as time to normalization, and found very similar results when compared to model-based graphs.[8]   
Quartiles were compared with one another regarding age at diagnosis and percentage male using 
Kruskal-Wallis and Chi-square methods, respectively. 
 
 Results 
In this total cohort, the median age at diagnosis was 11.3 months and 71% of the subjects were 
male.  Initial immunoglobulin determination was obtained most frequently because of recurrent otitis 
media and upper respiratory tract infection (67%), recurrent lower respiratory tract infection (24%) or 
failure to thrive (14%).  (See Table I.)   
There was no statistically significant difference in age at diagnosis or percentage male when the 
study population was divided into quartiles on the basis of initial aggregate immunoglobulin isotypes as 
a percentage of normal.  (See Table II.)  There was a statistically significant association of quartile of 
aggregate immunoglobulin isotypes as percentile of age-adjusted lower limit of normal and time to 
resolution (p = 0.008).  The median time to resolution for the infants in the lowest quartile of 
immunoglobulins (≤81% of age-adjusted lower limits of normal) was greater than five years with only 
34% resolving in 3 years.  For infants in the highest quartile (≥130% of age-adjusted lower limits of 
normal) the median time to resolution was 9.9 months with 77% resolving in 3 years.  Results for the 
other two quartiles are intermediate, but not significantly different in those for the highest quartile.  
(See figure 1.)   
There was also no statistically significant difference in age at diagnosis and percentage male 
when the study population was divided into quartiles on the basis of initial IgG alone as percentage of 
normal.  (See Table III.)  There was a statistically significant association of quartile of isolated IgG 
percentile age-adjusted lower limit of normal and time to resolution (p=0.010).  The median time to 
resolution in the lowest quartile (≤78% of age-adjusted lower limits of normal) was greater than 5 years 
with 36% resolving in 3 years.  For infants in the highest quartile (≥128%) the median time to resolution 
was 14.5 months with 70% resolving in 3 years.  (See figure 2.)   
In agreement with previously reported findings,[8] male infants resolved more quickly than 
females (p=0.001).  The median time to resolution in males was 13 months with 73% resolving in 3 
years.  The median time to resolution in females was greater than 5 years, with 32% resolving in 3 years.    
Discussion 
 Although many presenting infants with hypogammaglobulinemia will have early resolution of 
their decreased immunoglobulin levels, thereby leading to a diagnosis of THI, a subset have significantly 
delayed normalization or receive alternative diagnoses.   It is important to discriminate between infants 
who are likely to have early resolution of hypogammaglobulinemia and infants who are likely to have 
persistence because there is evidence that infants with prolonged unresolved hypogammaglobulinemia 
are more likely to have recurrent infection and autoimmune problems.[7]   
This study confirms an easily understood hypothesis:  infants with mild or moderate decreases 
in initial aggregate immunoglobulin levels or IgG levels alone are more likely to outgrow their 
immunologic deficiency and to do so sooner when compared to infants with greater decreases in 
immunoglobulin levels.  Not surprisingly, infants with higher initial aggregate immunoglobulin levels 
have a greater probability of prompt resolution.  A major contribution of this study is that 
immunoglobulin levels have been delineated, using the concept of percentage normal for age, that 
allow a clinician to estimate the probability of resolution for hypogammaglobulinemia in infants without 
evidence of another primary immune deficiency by a particular age.  At the time of initial evaluation, 
immunologists may use aggregate immunoglobulin levels or initial IgG levels to predict probability of 
resolution, although the aggregate immunoglobulin level does so with greater power.  Although other 
markers such as cytokine measurements[3] or regulatory T-cell measurements,[5] have been associated 
with resolution of hypogammaglobulinemia, these markers are not readily available outside of a 
research setting and are therefore of little use to most clinicians.  Aggregate immunoglobulin as a 
percentage of minimal normal and IgG as a percentage of minimal normal can be easily calculated by a 
practicing clinician and may be of significant practical utility.  
As shown in previous studies, male gender was also associated with more prompt resolution of 
hypogammaglobulinemia.  It is unclear why hypogammaglobulinemic male infants tend to resolve their 
initial hypogammaglobulinemia more rapidly than female infants, but the finding has been noted in two 
prior studies involving 49 and 87 infants respectively (8) (2). It is also notable that the male gender was 
overrepresented in our study population, with males composing 71% of our patients.  Other studies of 
infants with hypogammaglobulinemia have also had similarly disproportionate numbers of male 
infants.[9, 10]  It is possible that studies defining “normal” immunoglobulin levels by age may not 
accurately reflect naturally occurring differences in immunoglobulin levels due to gender or racial 
differences, thereby predisposing male infants to being mistakenly diagnosed with 
hypogammaglobulinemia.    Further studies are needed to define the normal immunoglobulin 
maturation patterns between males and females.    
Conclusions 
These results suggest that if a term infant presents with hypogammaglobulinemia, protective 
specific antibody titers, and an absence of other known immune deficiency, an immunologist may use 
the sum of initial IgG + IgA + IgM to predict time to normalization.  Furthermore, the initial IgG level also 
allows estimation of time to resolution.  And, male gender was associated with more prompt resolution 
of symptoms.  Further study is warranted to elucidate regarding possible long-term sequelae of 
hypogammaglobulinemia during infancy and the pathophysiologic mechanisms that underlie 
hypogammaglobulinemia during infancy.  
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Fig. 1  Calculation used for initial grouping of subjects 
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Fig. 2  Calculation used for secondary grouping of subjects 
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Table I  Reasons immunoglobulins were initially obtained 
Upper respiratory tract infections 67% 
Lower respiratory tract infections 24% 
Failure to thrive/GI complaints 14% 
Skin infections 4% 
Recurrent fevers 3% 
Hematologic abnormalities 2% 
CNS infections 1% 
 
 
Table II  Descriptive statistics, based on initial aggregate (IgG + IgA + IgM) immunoglobulin percentage 
normal quartile 
 
1
st
 
quartile  
2
nd
  
quartile  
3
rd
 
quartile  
4
th
 
quartile  
P-
value  
N  25  25  25  25   
Range of immunoglobulin 
levels, viewed as a 
percent of normal  
≤81%  82-
104%  
105-
129%  
≥130%   
% male  71  72  60  80  0.54  
Median age at diagnosis 
(months)  
11  10  11  13  0.28  
 
 
Table III  Descriptive statistics, based on initial IgG immune``oglobulin percentage normal quartile 
  1
st
 
quartile  
2
nd
 
quartile  
3
rd
 
quartile  
4
th
 
quartile  
P-
value  
N  25  25  26  24   
Range of immunoglobulin 
levels, viewed as a 
percent of normal  
≤78%  79-
100%  
101-
127%  
≥128   
% male  76  60  77  71  0.533  
Median age at diagnosis 
(months)  
10  11  11  13  0.839 
 
Fig. 3   Probability of resolution in relationship to sum aggregate immunoglobulin percentage (IgG + IgA 
+ IgM) of age-adjusted normal 
 
 
Fig. 4  Probability of resolution in relationship IgG percentage of age-adjusted normal 
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 Fig. 5  Probability of resolution in relationship to gender
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